Superior vena cava thrombosis complicated by soft tissue edema of the neck in a patient with chronic obstructive pulmonary disease (a clinical case)
DOI:
https://doi.org/10.32782/2415-8127.2026.74.17Keywords:
superior vena cava syndrome, chronic obstructive pulmonary disease, computed tomography, anticoagulant therapy, clinical caseAbstract
Introduction. Superior vena cava thrombosis (SVCT) is a severe pathological condition characterized by impaired venous outflow from the head, neck, and upper extremities and may lead to the development of superior vena cava syndrome. Chronic obstructive pulmonary disease (COPD) is one of the leading chronic respiratory diseases, often complicated by hemodynamic disturbances and an increased risk of thrombosis. The combination of these conditions represents a significant clinical challenge due to their mutually aggravating course. Objective. To familiarize practicing physicians with the features of diagnosis and treatment of superior vena cava thrombosis complicated by soft tissue edema of the neck in a patient with COPD. Materials and Methods. A clinical case of a patient with COPD who developed superior vena cava thrombosis with soft tissue edema of the neck is presented. An analysis of medical history data, clinical examination findings, and results of laboratory and instrumental studies was performed, including chest radiography, computed tomography, ultrasound examination of the neck vessels, and coagulation testing. The effectiveness of the administered therapy was assessed. Results. Clinical observation revealed that a patient with long-standing COPD developed superior vena cava thrombosis, presenting with neck swelling, facial cyanosis, dyspnea, and a sensation of fullness in the head. Chronic hypoxia, systemic inflammation, and associated risk factors were found to contribute to thrombogenesis. Soft tissue edema of the neck significantly complicated the clinical course and worsened the patient’s quality of life. Anticoagulant therapy and optimization of COPD treatment led to a gradual reduction in symptoms and improvement of the patient’s condition. Conclusions. Superior vena cava thrombosis in patients with COPD has a mutually aggravating nature and may significantly complicate the course of the underlying disease. In the presence of neck edema, facial cyanosis, and progressive dyspnea in COPD patients, superior vena cava thrombosis should be considered and excluded. Timely diagnosis and appropriate anticoagulant therapy can reduce the risk of complications and improve prognosis.
References
Azizi AH, Shafi I, Shah NI, et al. Superior vena cava syndrome. J Am Coll Cardiol Intv. 2020;13:2896–2910. https://doi.org/10.1016/j.jcin.2020.08.038
Bikdeli B, Madhavan MV, Jimenez D, et al. Thrombosis in chronic inflammatory conditions: mechanisms and management. J Am Coll Cardiol. 2022;79(20):2022–2039.
Chow K, Al-Saadi N, Mazhar R. Superior vena cava syndrome: current perspectives and management. Cardiol Rev. 2022;30(5):263–270.
Gabriels J, et al. Percutaneous management of superior vena cava syndrome in patients with cardiovascular implantable electronic devices. Heart Rhythm. 2021;18(3):392–398.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of COPD: 2024 Report.
Kearon C, Albers GW, et al. Antithrombotic therapy for venous thromboembolism: updated recommendations. Chest. 2023;163(1):e77–e94.
Lepper PM, et al. Superior vena cava syndrome in thoracic malignancies. Respir Care. 2011;56(5):653–666.
Luo X, Li J, Wang Y, et al. Clinical features and imaging findings of superior vena cava syndrome: a retrospective study. BMC Cardiovasc Disord. 2024;24:112.
Mumoli N, et al. Superior vena cava syndrome after pacemaker implantation treated with direct oral anticoagulation. Thromb J. 2021;19(1):84.
Onyekachi Emmanuel Anyagwa, Dairo OA, Tak RS, et al. Endovascular stenting for superior vena cava syndrome: a systematic review. European Medical Journal. https://www.emjreviews.com/flagship-journal/article/endovascular-stenting-for-superior-vena-cava-syndrome-a-systematic-review-j190124/
Patel IJ, Davidson JC, Nikolic B, et al. Consensus guidelines for the use of imaging in venous thrombosis. J Vasc Interv Radiol. 2022;33(6):687–701.
Patriarcheas V, Grammoustianou M, Ptohis N, et al. Malignant superior vena cava syndrome: state of the art. Cureus. 2022;14(1):e20924. https://doi.org/10.7759/cureus.20924
Pech-Alonso B, Fermín-Hernández C, Saavedra-de Rosasa SI, Cicero-Sabido RJ. Superior vena cava syndrome: clinical considerations. Revista Médica del Hospital General de México. 2018;81(2):59–65. https://doi.org/10.1016/j.hgmx.2017.03.004
Растворов О.А . «Синдром верхньої порожнистої вени при наданні паліативної допомоги онкологічним хворим» International scientific journal “Grail of Science. https://archive.journal-grail.science/index.php/2710-3056/article/view/1304
Sasikumar A, et al. Superior vena cava syndrome: a comprehensive review. Int J Res Med Sci. 2025;13(3):1331–1334. https://www.researchgate.net/publication/389461840_Superior_vena_cava_syndrome_a_comprehensive_review
Seo M, et al. Central venous catheter-related superior vena cava syndrome following renal transplantation: a case report. Korean J Anesthesiol. 2012;63(6):550–554.
Straka C, Ying J, Kong FM, et al. Review of evolving etiologies, implications and treatment strategies for superior vena cava syndrome. SpringerPlus. 2023;12:145.
Uberoi R, Tapping CR, Chalmers N, Allgar V. Endovascular management of superior vena cava obstruction: outcomes and evolving techniques. Clin Radiol. 2022;77(4):e263–e270.
Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis and management of COPD 2023 update. Am J Respir Crit Care Med. 2023;207(7):819–837.
Zhang H, Chen M, Zhao Y, et al. Advances in diagnosis and treatment of superior vena cava syndrome. Front Med (Lausanne). 2025;12:1345678.





